1. CVS revenue grew 8% to $103 billion, exceeding expectations. 2. Adjusted EPS forecast raised to mid-$6, despite a $5.7 billion loss. 3. High debt and weak profit margins present risks for investors. 4. Stock considered 'cheap but risky' compared to S&P 500. 5. Investors should assess risk tolerance before buying CVS stock.